These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 2863851)

  • 1. The window of vulnerability in the ontogeny of the dopamine receptor.
    Miller JC; Friedhoff AJ
    Psychopharmacol Bull; 1985; 21(3):683-5. PubMed ID: 2863851
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390.
    Hess EJ; Creese I
    Psychopharmacol Bull; 1986; 22(3):605-12. PubMed ID: 2879304
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple forms of the D1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects.
    Mailman RB; Schulz DW; Kilts CD; Lewis MH; Rollema H; Wyrick S
    Psychopharmacol Bull; 1986; 22(3):593-8. PubMed ID: 2879302
    [No Abstract]   [Full Text] [Related]  

  • 4. Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats.
    Zuo J; Liu Z; Ouyang X; Liu H; Hao Y; Xu L; Lu XH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):387-97. PubMed ID: 17935847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic CNS effects: acute and chronic studies.
    Bunney BS
    Psychopharmacol Bull; 1979 Jan; 15(1):57-8. PubMed ID: 33410
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dopaminergic receptors, multiple targets for neuroleptics].
    Martres MP; Sokoloff P; Giros B; Bouthenet ML; Pilon C; Lannfelt L; Schwartz JC
    Ann Med Psychol (Paris); 1992; 150(2-3):119-23. PubMed ID: 1364189
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine receptor pharmacology.
    Seeman P; Van Tol HH
    Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):602-8. PubMed ID: 8104554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain dopamine receptors.
    Seeman P
    Pharmacol Rev; 1980 Sep; 32(3):229-313. PubMed ID: 6117090
    [No Abstract]   [Full Text] [Related]  

  • 9. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific blockade of dopamine receptors by neuroleptic agents in human brain.
    Borison RL; Fields JZ; Diamond BI
    Neuropharmacology; 1981 Dec; 20(12B):1321-2. PubMed ID: 6119643
    [No Abstract]   [Full Text] [Related]  

  • 11. Adaptive changes in brain dopamine function as a result of neuroleptic treatment.
    Jenner P; Marsden CD
    Adv Neurol; 1988; 49():417-31. PubMed ID: 2894127
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
    J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptors and antipsychotic drug response.
    Sunahara RK; Seeman P; Van Tol HH; Niznik HB
    Br J Psychiatry Suppl; 1993 Dec; (22):31-8. PubMed ID: 7906523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain.
    Scatton B
    Adv Biochem Psychopharmacol; 1980; 24():31-6. PubMed ID: 6105783
    [No Abstract]   [Full Text] [Related]  

  • 15. [A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain].
    Matsubara R
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):570-82. PubMed ID: 7687976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity.
    Scatton B
    J Pharmacol Exp Ther; 1982 Jan; 220(1):197-202. PubMed ID: 6118430
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of neuroleptic drugs on endogenous opioid peptides in the rat.
    Höllt V
    Mod Probl Pharmacopsychiatry; 1981; 17():1-18. PubMed ID: 6120450
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of the pharmacological modulation of the brain dopamine systems on epileptic activity in rats].
    Selitskiĭ GV
    Patol Fiziol Eksp Ter; 1987; (6):24-7. PubMed ID: 2895449
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine-sensitive adenylate cyclase and receptor binding activities after acute and chronic neuroleptic drug treatment.
    Clement-Cormier Y
    Adv Biochem Psychopharmacol; 1980; 24():103-11. PubMed ID: 6105768
    [No Abstract]   [Full Text] [Related]  

  • 20. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.